Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist

Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist

US Patent 11203624 · Granted Dec 21, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing levulinic acid2025
Cache circuit that selectively stores data blocks to dynamically optimize for re2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
Methods for treating heterotopic ossification2025
ALK7 binding proteins and uses thereof2025
Compositions and methods for treating pulmonary hypertension2025
Single-arm type I and type II receptor fusion proteins and uses thereof2025
ALK4:actriib heteromultimers and uses thereof2025
Variant ActRIIB proteins and uses thereof2025
Methods and compositions for treating myelofibrosis2025
Methods and compositions for treating myelofibrosis2025
Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides2025